Acknowledgements
The authors would like to thank the study site personnel, as well as patients and their families, for their participation in this study. This study was funded by Therapim Pty Ltd, a wholly-owned subsidiary of APIM Therapeutics AS. The investigational drug ATX-101 was provided by Therapim Pty Ltd. Novotech